Literature DB >> 7157214

Relation between severity of mitral valve disease and results of routine lung function tests in non-smokers.

K M Rhodes, K Evemy, S Nariman, G J Gibson.   

Abstract

The effects of mitral valve disease on lung function have been studied in 26 non-smoking patients by relating values for lung volumes and carbon monoxide transfer factor (TLCO) to various indices of cardiac function measured at catheterisation. In general, more severe mitral disease was associated with greater abnormalities of lung function. Reductions of the one-second forced expiratory volume, vital capacity, TLCO and transfer coefficient, and increase in residual volume were all significantly related to the severity of mitral valve disease. In addition, the cardiothoracic ratio, measured radiographically, showed an inverse correlation with both vital capacity and total lung capacity. Although some of the consequences of mitral valve disease on lung function resemble those of primary airway disease, useful distinguishing points are the relative normality of the forced expiratory ratio and the absence of an increase in total lung capacity.

Entities:  

Mesh:

Year:  1982        PMID: 7157214      PMCID: PMC459420          DOI: 10.1136/thx.37.10.751

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  PULMONARY DIFFUSING CAPACITY IN MITRAL VALVE DISEASE.

Authors:  J M REID; J G STEVENSON
Journal:  Br Heart J       Date:  1963-11

2.  THE DIFFUSING CHARACTERISTICS AND PRESSURE-VOLUME RELATIONSHIPS OF THE PULMONARY CAPILLARY BED IN MITRAL VALVE DISEASE.

Authors:  R M MCCREDIE
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

3.  Pulmonary function studies in patients with mitral stenosis.

Authors:  B L FRIEDMAN; J DE MACIAS J; P N YU
Journal:  Am Rev Tuberc       Date:  1959-03

4.  Pulmonary function in mitral valve disease; hemodynamic and ventilatory studies.

Authors:  G C DOGLIOTTI; P F ANGELINO; A BRUSCA; R GARBAGNI; F GAVOSTO; G MAGRI; E MINETTO
Journal:  Am J Cardiol       Date:  1959-01       Impact factor: 2.778

5.  Residual lung volume in mitral disease.

Authors:  R GARBAGNI; P F ANGELINO; A BRUSCA; E MINETTO
Journal:  Br Heart J       Date:  1958-10

6.  A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Authors:  W S BLAKEMORE; R E FORSTER; J W MORTON; C M OGILVIE
Journal:  J Clin Invest       Date:  1957-01       Impact factor: 14.808

7.  Pulmonary blood distribution and oxygen diffusion in mitral stenosis.

Authors:  N O FOWLER; R CUBBERLY; E DORNEY
Journal:  Am Heart J       Date:  1954-07       Impact factor: 4.749

8.  Ventilatory studies in mitral stenosis; a comparison with findings in primary pulmonary disease.

Authors:  N R FRANK; D W CUGELL; E A GAENSLER; L B ELLIS
Journal:  Am J Med       Date:  1953-07       Impact factor: 4.965

9.  Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I.

Authors:  R GORLIN; S G GORLIN
Journal:  Am Heart J       Date:  1951-01       Impact factor: 4.749

10.  Mechanics of breathing in mitral stenosis.

Authors:  T E Wood; P McLeod; N R Anthonisen; P T Macklem
Journal:  Am Rev Respir Dis       Date:  1971-07
View more
  4 in total

1.  Effects of mitral valve surgery on static lung function and exercise performance.

Authors:  K M Rhodes; K Evemy; S Nariman; G J Gibson
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

2.  Pulmonary function derangements in isolated or predominant mitral stenosis - Preoperative evaluation with clinico-hemodynamic correlation.

Authors:  Usha T Parvathy; Rajesh Rajan; Alexander Georgevich Faybushevich
Journal:  Interv Med Appl Sci       Date:  2014-06-04

3.  Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure.

Authors:  S Puri; B L Baker; C M Oakley; J M Hughes; J G Cleland
Journal:  Br Heart J       Date:  1994-08

4.  Pulmonary hypertension in left heart disease.

Authors:  Pratishtha Mehra; Vimal Mehta; Rishi Sukhija; Anjan K Sinha; Mohit Gupta; M P Girish; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-17       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.